Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

50.75
Delayed Data
As of Oct 16
 +0.46 / +0.91%
Today’s Change
41.93
Today|||52-Week Range
63.40
-8.69%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close50.29
Today’s open49.00
Day’s range48.96 - 51.04
Volume797,626
Average volume (3 months)751,677
Market cap$7.7B
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+43.99%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book6.34

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-1.11-0.91%
SGENSeattle Genetics Inc-0.11-0.17%
TSROTESARO Inc-2.69-2.19%
JAZZJazz Pharmaceuticals...-0.88-0.62%
Data as of 3:59pm ET, 10/16/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts